Bob Ruley is running Boston for Team Eye and Ear to support "treatments, cures, or options for children and adults with ...

Researchers at Mass Eye and Ear led the study, a Phase I/II clinical trial of 14 patients. In most cases, the therapy—a transplant of stem cells from the person’s other healthy eye—appeared ...

Novel stem cell therapy repairs 'irreversible' corneal damage in clinical trial Date: March 4, 2025 Source: Mass Eye and Ear Summary: Results from a phase 1/2 clinical trial of a novel stem cell ...

The treatment, called cultivated autologous limbal epithelial cells (CALEC), was developed at Mass Eye and Ear. The innovative procedure consists of removing stem cells from a healthy eye with a ...

Previous studies also have detected this risk. A 2024 study based at Mass Eye and Ear in Boston reported a more than fourfold increased risk of NAION with semaglutide, researchers said in ...